Page last updated: 2024-08-25

voacamine and Malignant Melanoma

voacamine has been researched along with Malignant Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arancia, G; Condello, M; Corinti, S; Cosentino, D; Di Felice, G; Gallo, FR; Meschini, S; Multari, G	1

Other Studies

1 other study(ies) available for voacamine and Malignant Melanoma

Article	Year
Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts. Journal of natural products, 2014, Apr-25, Volume: 77, Issue:4 Topics: Alkaloids; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fibroblasts; Fluorescent Antibody Technique; Humans; Ibogaine; Melanoma; Molecular Structure; Osteosarcoma	2014

Article

Year

Voacamine modulates the sensitivity to doxorubicin of resistant osteosarcoma and melanoma cells and does not induce toxicity in normal fibroblasts.

Journal of natural products, 2014, Apr-25, Volume: 77, Issue:4

Topics: Alkaloids; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Bone Neoplasms; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fibroblasts; Fluorescent Antibody Technique; Humans; Ibogaine; Melanoma; Molecular Structure; Osteosarcoma

2014